InMed Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

InMed Pharmaceuticals

11/11/2021 14:32

* InMed Pharmaceuticals Inc  INM.OQ  reported a quarterly
adjusted loss of 25 cents​​ per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 35 cents per share.
* Revenue was $5.15 thousand​;  analysts expected $250.00
thousand. 
* InMed Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 25 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* InMed Pharmaceuticals Inc shares had fallen by 23.4% this
quarter and lost 59.3% so far this year.
* The company reported a quarterly loss of $2.97 million.
* Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 02:32 p.m.
 ​All figures in US dollars unless otherwise stated